Sign in / Join Now
ETFs & Funds
management is doing a terrible job promoting their drugs. Have not heard ANY media coverage from their ALS or
They should be promoting their company/results of the drug trials in ALS and
/WSJ. Have not seen any media coverage.
Add a reply...
Latest StockTalks »
people get CYTK breaking news and analysis by email alert.
Get email alerts on CYTK »
Get latest price
From other sites
Cytokinetics' Amyotrophic Lateral Sclerosis Study Enrolled
at Zacks.com (Aug 18, 2016)
Cytokinetics Completes Enrollment In VITALITY-ALS, Phase 3 Clinical Trial Of Tirasemtiv In Patients With ALS
at TheStreet (Aug 17, 2016)
Cytokinetics (CYTK) Shares March Higher, Can It Continue?
at Zacks.com (Aug 4, 2016)
Cytokinetics (CYTK) Is Strong On High Volume Today
at TheStreet (Aug 1, 2016)
Cytokinetics, Inc. Reports Second Quarter 2016 Financial Results
at TheStreet (Jul 28, 2016)